Table 3.

Associations between depression, anxiety symptoms and HIV outcomes at the next visit, stratified by time of outcome assessment ^a

Time of outcome assessment	Models predicting viral suppression b			Models predicting complete ART adherence c
	aRR	95%CI	p‐values	aRR	95%CI	p‐values
Main predictor: depression symptoms
At three‐month visit	0.99	0.94 to 1.04	0.66	0.90	0.84 to 0.97	0.005
At six‐month visit	0.97	0.91 to 1.03	0.31	0.96	0.89 to 1.03	0.28
At twelve‐month visit	1.05	1.00 to 1.10	0.09	1.01	0.94 to 1.09	0.69
Main predictor: anxiety symptoms
At three‐month visit	0.96	0.89 to 1.03	0.30	0.87	0.79 to 0.96	0.005
At six‐month visit	0.96	0.86 to 1.07	0.50	0.90	0.79 to 1.03	0.14
At twelve‐month visit	1.09	1.02 to 1.17	0.02	1.04	0.96 to 1.13	0.36

ART, antiretroviral therapy; aRR, adjusted risk ratio; CI, confidence interval.

^aEach multivariable model has only one mental health predictor, either depression symptoms or anxiety symptoms at the previous time point. Models with the same outcome have the same set of covariates. Time presented in the first column is the time of assessment of viral suppression and ART adherence. aRRs were associated with a 5‐point increase in scores of depression or anxiety symptoms at the previous time point

^bmodels predicting viral suppression control for age, viral suppression at baseline, intervention exposure, time, interaction of time × depression/anxiety symptoms

^cmodels predicting adherence control for marital status, alcohol dependence at baseline, adherence at baseline, intervention exposure, time, interaction of time × depression/anxiety symptoms